Skip to main content
. 2009 Mar;123(1-4):65–78. doi: 10.1159/000184693

Table 1.

CNVs detected in patient families with Affymetrix 500K microarrays

Cytoband
Estimated size (bp)
Type
Status in childrena
Gene(s) involved
Family of Case 1
Proband
3q29 2,399,433 gain de novo multiple genes; overlapping with 3q29 microdeletion syndrome (Willatt et al., 2005)
6q16.1 60,058 loss inherited (paternal)b no genes; overlaps known CNVs
8p23.1 407,187 gain inherited (maternal) FAM86B1, DEFB130, LOC44005; region of segmental duplications and known CNVs
Mother
8p23.1 202,167 gain no known genes; numerous cDNAs; region of segmental duplications and known CNVs
10q11.1-q11.21 906,591 gain ZNF33B, BMS1L and numerous cDNAs; region of segmental duplications and known CNVs
11q22.1 626,031 loss cDNA AK128111; overlaps known CNVs
15q11.2 1,908,357 loss OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
22q11.23 211,233 gain LRP5L and multiple cDNAs; region of segmental duplications and known CNVs
Father
6q16.1 60,058 loss no genes; overlaps known CNVs
10q11.22 124,801 gain no genes; region of segmental duplications and known CNVs
14q11.2 153,147 gain OR4N2, OR4K2, OR4K5, OR4K1 (odorant receptor gene cluster)
Family of Case 2
Mother
3q29 2,086,988 gain multiple genes; overlapping with 3q29 microdeletion syndrome (Willatt et al., 2005)
7q11.23 428,467 gain POMZP3, UPK3B, cDNA BC043544, intron of cDNA BC013192
14q21.1 357,718 loss cDNA BX248273; encompasses small CNV
Proband
3q29 2,086,988 gain inherited (apparently maternal) multiple genes; overlapping with 3q29 microdeletion syndrome (Willatt et al., 2005)
7q11.23 422,126 gain inherited (apparently maternal) POMZP3, most of UPK3B, cDNA BC043544, intron of cDNA BC013192
14q11.2 219,459 gain unknown OR4Q3, OR4M1, OR4N2, OR4K2, OR4K5, OR4K1 (odorant receptor cluster)
14q21.1 368,345 loss inherited (maternal)b cDNA BX248273; encompasses small CNV
15q11.2 1,662,281 gain unknown OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
17q21.31 183,068 gain unknown 5′ end of KIAA1267, and cDNAs BC018467 and BC000924
Family of Case 3
Proband
3q29 1,893,889 gain inherited (paternal) multiple genes; overlapping with 3q29 microdeletion syndrome (Willatt et al., 2005)
8p23.2-p23.1 176,963 gain inherited (paternal) 5′ end of MCPH1, and cDNAs including AK025595
15q11.2 1,378,020 loss de novoc OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
19q13.42 456,306 gain inherited (maternal) cDNA BX248273; encompasses small CNV
Mother
12q24.31 114,901 gain 3′ ends of P2RX7 and CAMKK2, and all of P2RX4
19q13.42 996,692 gain multiple genes
brother 1
1q31.3 142,667 loss inherited (paternal)d CFHR3, CFHR1 and 5′ end of CFHR4
3q29 1,893,889 gain inherited (paternal) multiple genes; overlapping with 3q29 microdeletion syndrome (Willatt et al., 2005)
8p23.2-p23.1 221,809 gain inherited (paternal) 5′ end of MCPH1, and cDNAs including AK025595
10q11.22 1,087,629 gain inherited (paternal) GPRIN2, PPYR1, ANXA8L1, ANXA8, and multiple other cDNAs
12q24.31 79,614 gain inherited (maternal) 3′ ends of P2RX7 and CAMKK2, all of P2RX4
14q11.2 229,920 gain inherited (paternal) OR4Q3, OR4M1, OR4N2, OR4K2, OR4K5, OR4K1 (odorant receptor gene cluster)
15q11.2 1,662,281 gain de novoc OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
19q13.42 857,878 gain inherited (maternal) multiple genes
Brother 2
3q29 1,893,889 gain inherited (paternal) multiple genes; overlapping with 3q29 microdeletion syndrome (Willatt et al., 2005)
4q24 831,405 gain inherited (paternal) TACR3
8p23.2-p23.1 198,636 gain inherited (paternal) 5′ end of MCPH1, and cDNAs including AK025595
10q11.22 848,700 gain inherited (paternal) SYT15, GPRIN2, PPYR1, ANXA8L1
15q11.2 1,662,281 gain de novoc OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
19q13.42 541,228 gain inherited (maternal) multiple genes
Father
3q29 1,893,889 gain multiple genes; overlapping with 3q29 microdeletion syndrome (Willatt et al., 2005)
4q24 556,763 gain TACR3
8p23.2-p23.1 224,359 gain 5′ end of MCPH1, and cDNAs including AK025595
10q11.22 848,700 gain SYT15, GPRIN2, PPYR1, ANXA8L1
14q11.2 222,787 gain OR4Q3, OR4M1, OR4N2, OR4K2, OR4K5, OR4K1 (odorant receptor gene cluster)
Case 4
2q27.3 81,134 loss unknown multiple cDNAs; encompassed by known CNV
3q29 2,041,109 gain unknown multiple genes; overlapping with 3q29 microdeletion syndrome (Willatt et al., 2005)
6q24.2-q24.3 2,637,073 gain unknown 3′ end of UTRN, EPM2A, GRM1, RAB32, FLJ44955, FBX030, SHPRH, various cDNAs; encompasses several small CNVs
14q11.2 249,343 loss unknown OR4N2, OR4K2, OR4K5, OR4K1, OR4K13, OR4K14, OR4K15 (odorant receptor gene cluster; encompasses known CNV and segmental duplications)
Xp11.23 67,327 loss unknown ZNF630, SSX6; encompasses known CNV and segmental duplications
a

Parental origin is inferred assuming Mendelian inheritance of CNV events. In Case 2, these are apparently maternal; however, the father's sample was not available for analysis.

b

Parental origin of losses in Case 1 and Case 2 were confirmed by examination of SNP genotypes in these regions.

c

The 15q11.2 region is very complex and apparently de novo events may actually be inherited; in particular, the loss in Case 3 contains multiple heterozygous SNPs and is therefore not a simple hemizygous deletion.

d

SNP genotypes are consistent with paternal inheritance of the 1q31.3 loss in this individual. The corresponding CNV in the father was identified by only one algorithm and thus is not reported.